In this video from the 2015 ONS meeting, Dr. Sipples talks about effective management of side effects for patients taking afatinib, an oral, targeted agent for lung cancer.
Rebecca Sipples, DNP, APRN, ACNP, AOCNP
Advertisement
Articles by Rebecca Sipples, DNP, APRN, ACNP, AOCNP
Advertisement
Latest Updated Articles
- Practical Management of Adverse Events Associated With Afatinib
Published: April 28th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
3
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
4
FDA Approves Revumenib in R/R NPM1-Mutant AML
5
